Aarkstore Enterprise--jilin Aodong Medicine Industry Group Co., Ltd. (623) - Financial And Strategic

JiLin AoDong Medicine Industry Group Co., Ltd

JiLin AoDong Medicine Industry Group Co., Ltd. (623) - Financial and Strategic Analysis Review

JiLin AoDong Medicine Industry Group Co., Ltd. (Jilin Aodong) is a pharmaceutical company engaged, that is engaged in the manufacture and marketing of pharmaceuticals products. The company also provides pharmaceutical packaging products. Its product portfolio includes various drugs for providing nutrients for brains, curing brain and heart diseases, and blood-generation function. Jilin Aodong's products are available in the forms of capsules, granules, oral tablet, ointment, injection powder, syrup, pills, liquor injection and chinese herbal pieces. The company conducts research and development on methods to remake tonics into tablets, instant drinks, injections, and sprays.

This comprehensive SWOT profile of JiLin AoDong Medicine Industry Group Co., Ltd. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of JiLin AoDong Medicine Industry Group Co., Ltd., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information, please visit:

http://www.aarkstore.com/reports/JiLin-AoDong-Medicine-Industry-Group-Co-Ltd-623-Financial-and-Strategic-Analysis-Review-49053.html

Jessica

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com/

by: Aarkstore Enterprise

POST COMMENT

Aarkstore Enterprise--guangxi Beisheng Pharmaceutical Co., Ltd (600556) - Financial And Strategic An Arca Biopharma, Inc. (abio) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Shanghai Chlor Alkali Chemical Co Ltd 900908 Financial And Strategic Analysis Review --- Aarkstore Aarkstore Enterprise-- Survey Of Ethoxylate In China Aarkstore Enterprise-- Yellow Phosphorus Export Situation In China Aarkstore Enterprise--yellow Phosphorus Export In China 2008-q1 2009 Aarkstore Enterprise---world Outlook Of Glyphosate 2009-2014 Aarkstore Enterprise--survey Of Glufosinate In China Aarkstore Enterprise-- The Survey Of 2,4-d In China Aarkstore Enterprise---the Survey Of Sorbitol In Asia Pacific Aarkstore Enterprise--2010 U.s. Cd, Record & Tape Recording Industry Report Aarkstore Enterprise--2010 U.s. Cement Manufacturing Industry Report Aarkstore Enterprise -carbon Trading And The Effect Of The Copenhagen Agreement: Technical Options